Table 2 Clinicopathologic characteristics of training and test cohorts.
From: Blood-borne miRNA profile-based diagnostic classifier for lung adenocarcinoma
Variable | Lung adenocarcinoma patients | Healthy subjects | ||||
|---|---|---|---|---|---|---|
Training | Test | p | Training | Test | p | |
No. of samples | 143 | 110 | 49 | 52 | ||
Age at diagnosis (years)c | 65.9 ± 9.8a | 65.0 ± 9.9 | 0.494b | 66.3 ± 8.9 | 65.7 ± 9.7 | 0.774b |
Gender | ||||||
Male | 76 | 62 | 0.703c | 28 | 30 | 1.000c |
Female | 67 | 48 | 21 | 22 | ||
pStage | ||||||
I | 80 | 65 | 0.273c | |||
II | 21 | 15 | ||||
III | 37 | 30 | ||||
IV | 5 | 0 | ||||
Smoking historyd | 728.2 ± 770.2 (n = 116) | 634.4 ± 777.0 (n = 70) | 0.424b | 320.5 ± 578.3 (n = 48) | 272.6 ± 459.6 (n = 51) | 0.648b |
